Sfoglia per AUTORE
SCIASCIA S
Collezione ASL Città di Torino

  

Items : 232

ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the APS ACTION Clinical Database and Repository. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2024 Oct 18:keae583. doi: 10.1093/rheumatology/keae583.

2024
ASL Città di Torino

Cecchi I; Radin M; Foddai SG; Barinotti A; Andrade D; Tektonidou MG; Pengo V; Ruiz-Irastorza G; Belmont HM; Lopez Pedrera C; Fortin PR; Gerosa M; de Jesus G; Atsumi T; Ji L; Efthymiou M; Branch DW; Nalli C; Rodriguez-Almaraz E; Petri M; Cervera R; Knight J; Artim-Esen B; Willis R; Bertolaccini ML; Cohen H; Erkan D; Sciascia S;

2023 ACR/EULAR classification criteria in existing research cohorts: an international study. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2024 Oct 1;63(10):2770-2775. doi: 10.1093/rheumatology/keae058.

2024
ASL Città di Torino

Sciascia S; Roccatello D; Rossi D; Gimen Alonso C; Alba P; Rubini E; Barinotti A; Radin M; Cecchi I; Foddai SG;

The role of kidney biopsy in the diagnosis of membranous nephropathy. in Clinical kidney journal / Clin Kidney J. 2024 Oct 3;17(10):sfae292. doi: 10.1093/ckj/sfae292. eCollection 2024 Oct.

2024
ASL Città di Torino

Sciascia S; Fenoglio R; Roccatello D;

Extremely Long-Lasting B-cell Depletion and BAFFling Effects Following Obinutuzumab-Based Regimen in Lupus Nephritis. in Kidney international reports / Kidney Int Rep. 2024 Aug 10;9(10):3079-3080. doi: 10.1016/j.ekir.2024.08.008. eCollection 2024 Oct.

2024
ASL Città di Torino

Fenoglio R; Martins E; Mao HA; Rossi D; Schindler T; De Simone E; Sciascia S; Roccatello D;

Lymphatic System and the Kidney: From Lymphangiogenesis to Renal Inflammation and Fibrosis Development. in International journal of molecular sciences / Int J Mol Sci. 2024 Mar 1;25(5):2853. doi: 10.3390/ijms25052853.

2024
ASL Città di Torino

Roccatello D; Baldovino S; Naretto C; Sciascia S; Stasi E;

Pediatric Presentation of Antiphospholipid Syndrome: A Review of Recent Literature With Estimation of Local Prevalence. in Seminars in thrombosis and hemostasis / Semin Thromb Hemost. 2024 Mar;50(2):182-187. doi: 10.1055/s-0043-1764472. Epub 2023 Mar 20.

2024
ASL Città di Torino
AOU Città della Salute di Torino

Sciascia S; Roccatello D; Barinotti A; Menegatti E; Baldovino S; Foddai SG; Cioffi M; Radin M; Cecchi I; Arbrile M; Montin D; Farinasso L;

Differential biologic response between venous and microvascular endothelium exposed to Antiphospholipid Syndrome (APS) patients' serum. in Vascular pharmacology / Vascul Pharmacol. 2024 Jun;155:107296. doi: 10.1016/j.vph.2024.107296.

2024
ASL Città di Torino

Arrigo E; Marinotti C; Shelton-Agar FMA; Barinotti A; Radin M; Sciascia S; Mancardi D;

Might maintenance therapy be discontinued once clinical remission is achieved in ANCA-associated vasculitis? in Autoimmunity reviews / Autoimmun Rev. 2024 Jan;23(1):103438. doi: 10.1016/j.autrev.2023.103438. Epub 2023 Aug 30.

2024
ASL Città di Torino

Roccatello D; Little MA; Iorio L; Sciascia S; Padoan R; Nic An Ríogh E;

Can anticoagulation be withdrawn in APS patients after aPL negativization? in Autoimmunity reviews / Autoimmun Rev. 2024 Jan;23(1):103427. doi: 10.1016/j.autrev.2023.103427. Epub 2023 Aug 25.

2024
ASL Città di Torino

Tincani A; Enriquez Merayo E; Moschetti L; Cuadrado MJ; Sciascia S;

The estimated prevalence of antiphospholipid antibodies and criteria-antiphospholipid syndrome in subjects with renal thrombotic microangiopathy. in Lupus / Lupus. 2024 Jan;33(1):75-82. doi: 10.1177/09612033231217351. Epub 2023 Nov 20.

2024
ASL Città di Torino

Versino E; Lembo D; Roccatello D; Sciascia S; Olugbogi A; Tesio N; Ugo H; Zanetti E; Zevallos C; Campa L; Gazzola V; Aluf O; Parente S; Radin M;

Epidemiology of antiphospholipid syndrome: macro- and microvascular manifestations. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2024 Feb 6;63(SI):SI24-SI36. doi: 10.1093/rheumatology/kead571.

2024
ASL Città di Torino

Gaspar P; Tektonidou MG; Sciascia S;

Lupus anticoagulant mixing studies and normalization of results how best to proceed. in International journal of laboratory hematology / Int J Lab Hematol. 2024 Feb;46(1):183-189. doi: 10.1111/ijlh.14187. Epub 2023 Oct 17.

2024
AO Ordine Mauriziano
AOU Città della Salute di Torino
ASL Città di Torino
AOU Novara

Sciascia S; Valesella P; Muccini E; Sampietro S; Rolla R; Papandrea M; Beltrami E; Cabodi D; Bairo A; Montaruli B;

Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-D Report: Multicriteria Decision Analysis. in Arthritis care & research / Arthritis Care Res (Hoboken). 2024 Aug 12. doi: 10.1002/acr.25415.

2024
ASL Città di Torino

Erkan D; Naden R; Costenbader K; Yelnik C; Hendry A; Wahl D; Willis R; Tektonidou MG; Sciascia S; Seshan SV; Petri M; Sanna G; Ortel TL; Lockshin MD; Levy RA; Levine SR; Gómez-Puerta JA; Guillemin F; Garcia D; Devreese KMJ; Frances C; Crowther M; Ramires de Jesus G; Branch DW; Costedoat-Chalumeau N; Bertolaccini ML; Avcin T; Andrade D; Amigo MC; et alii...

Antiphospholipid antibody testing. in Medicina clinica / Med Clin (Barc). 2024 Aug;163 Suppl 1:S4-S9. doi: 10.1016/j.medcli.2024.06.002.

2024
ASL Città di Torino
AO Ordine Mauriziano

Sciascia S; Infantino M; Montaruli B;

Assessing the steroid-sparing effect of biological agents in randomized controlled trials for lupus: a scoping review. in Immunologic research / Immunol Res. 2024 Aug;72(4):538-553. doi: 10.1007/s12026-024-09463-y. Epub 2024 Mar 9.

2024
ASL Città di Torino

Roccatello D; Fenoglio R; Barinotti A; Cecchi I; Radin M; Foddai SG; Arbrile M; Sciascia S;

Recommendations for physical activity and exercise in persons living with Systemic Lupus Erythematosus (SLE): consensus by an international task force. in RMD open / RMD Open. 2024 Apr 4;10(2):e004171. doi: 10.1136/rmdopen-2024-004171.

2024
ASL Città di Torino

Parodis I; Md Yusof MY; Soriano-Maldonado A; Ugarte-Gil MF; Sheikh SZ; Sciascia S; Padjen I; Li L; Mak A; Haglo H; Hambly K; Kinnett-Hopkins D; Su KY; Legge A; Davergne T; Fuentes Y; Bordier G; Geneton S; Arnaud L; Appenzeller S; Goepfert T; Blaess J;

From inflammation to renal fibrosis: A one-way road in autoimmunity? in Autoimmunity reviews / Autoimmun Rev. 2024 Apr;23(4):103466. doi: 10.1016/j.autrev.2023.103466. Epub 2023 Oct 15.

2024
ASL Città di Torino

Fornoni A; Glassock R; Sciascia S; Sethi S; Roccatello D; Lan HY;

Type I interferon pathway activation across the antiphospholipid syndrome spectrum: associations with disease subsets and systemic antiphospholipid syndrome presentation. in Frontiers in immunology / Front Immunol. 2024 Mar 14;15:1351446. doi: 10.3389/fimmu.2024.1351446. eCollection 2024.

2024
ASL Città di Torino

Sciascia S; Rodríguez-Carrio J; Roccatello D; Suárez A; Foddai SG; Menegatti E; Radin M; Barinotti A; Cecchi I;

Is the cost of the new home dialysis techniques still advantageous compared to in-center hemodialysis? An Italian single center analysis and comparison with experiences from western countries. in Frontiers in medicine / Front Med (Lausanne). 2024 Mar 11;11:1345506. doi: 10.3389/fmed.2024.1345506. eCollection 2024.

2024
ASL Città di Torino

Roccatello D; Sciascia S; Morero D; Borca M; Giorda E; Iadarola GM;

Case report: Timing of eculizumab treatment in catastrophic antiphospholipid syndrome. in Frontiers in immunology / Front Immunol. 2024 Sep 10;15:1460317. doi: 10.3389/fimmu.2024.1460317. eCollection 2024.

2024
ASL Città di Torino

Roccatello D; Sciascia S; Ruggenenti P; Gastoldi S; Mataj B; Carrara C;

Safety and efficacy of pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) in patients with glomerular diseases who received rituximab. in Clinical kidney journal / Clin Kidney J. 2023 May 15;16(9):1465-1468. doi: 10.1093/ckj/sfad111. eCollection 2023 Sep.

2023
ASL Città di Torino

Roccatello D; Menegatti E; Baldovino S; Barinotti A; Guidetti MG; Cinnirella G; Crosasso P; Cecchi I; Radin M; Foddai SG; Fenoglio R; Rilat MLA; Sciascia S;

[Management of Cast Nephropathy]. in Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia / G Ital Nefrol. 2023 Oct 3;40(Suppl 81):2023-S81.

2023
ASL Città di Torino

Roccatello D; Sciascia S; Bugliosi F; Geraci G; Careddu A; Cortazzi S; Fenoglio R; De Simone E;

[Renal Side Effects of Novel Molecular Targeted Oncologic Agents]. in Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia / G Ital Nefrol. 2023 Oct 3;40(Suppl 81):2023-S81.

2023
ASL Città di Torino

Roccatello D; Sciascia S; Marchisio M; Terzolo E; Rabajoli G; Cortazzi S; Fenoglio R;

[Renal Replacement Therapy in Cancer Patients with AKI]. in Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia / G Ital Nefrol. 2023 Oct 3;40(Suppl 81):2023-S81.

2023
ASL Città di Torino

Pozzato M; Fenoglio R; Caruso N; Ceruti C; Amore G; Sciascia S; Roccatello D;

[Management of the Oncological Patient with Chronic Renal Failure]. in Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia / G Ital Nefrol. 2023 Oct 3;40(Suppl 81):2023-S81.

2023
ASL Città di Torino

Fenoglio R; Cortazzi S; Guarino A; Longo R; Caniggia I; Sciascia S; Roccatello D;

[Cancer and the Kidney: A Deadly Embrace]. in Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia / G Ital Nefrol. 2023 Oct 3;40(Suppl 81):2023-S81.

2023
ASL Città di Torino

Fenoglio R; Sciascia S; Nescis L; La Rosa A; Roccatello D; Bertinetto F; Cortazzi S;

2023 ACR/EULAR antiphospholipid syndrome classification criteria. in Annals of the rheumatic diseases / Ann Rheum Dis. 2023 Oct;82(10):1258-1270. doi: 10.1136/ard-2023-224609. Epub 2023 Aug 28.

2023
ASL Città di Torino

Sciascia S; Seshan SV; Roubey R; Sanna G; Raimboug Q; Gomez-Puerta JA; Pengo V; Petri M; Pons-Estel G; Orsolini G; Ortel TL; Meroni PL; Musial J; Mayer-Pickel K; Lockshin MD; Limper M; Levy RA; Levine SR; Legault K; Laskin C; Lee AI; Knight JS; Kello N; Leaf RK; Jordan N; Gris JC; Garcia D; Frances C; Duarte-García A; et alii...

The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria. in Arthritis & rheumatology (Hoboken, N.J.) / Arthritis Rheumatol. 2023 Oct;75(10):1687-1702. doi: 10.1002/art.42624. Epub 2023 Aug 28.

2023
ASL Città di Torino

Sciascia S; Seshan SV; Sanna G; Roubey R; Raimboug Q; Gomez-Puerta JA; Petri M; Pons-Estel G; Pengo V; Ortel TL; Orsolini G; Meroni PL; Musial J; Mayer-Pickel K; Lockshin MD; Limper M; Levy RA; Levine SR; Laskin C; Lee AI; Legault K; Knight JS; Kello N; Leaf RK; Jordan N; Garcia D; Gris JC; Frances C; Duarte-Garcia A; et alii...

Pursuing appropriateness in antiphospholipid antibodies testing: Feasibility study with a reflex test approach for anti-?2GPI I domain. in Autoimmunity reviews / Autoimmun Rev. 2023 Nov;22(11):103454. doi: 10.1016/j.autrev.2023.103454. Epub 2023 Sep 22.

2023
ASL Città di Torino

Sciascia S; Roccatello D; Menegatti E; Elnaz R; Rubini E; Aluf O; Barinotti A; Cecchi I; Radin M; Manfredi M; Benucci M; Infantino M; Foddai S;

The steroid-sparing effects of a mycophenolate mofetil-based regimen in the management of immunoglobulin A nephropathy in patients with histologically active lesions: A comparison with a control cohort receiving conventional therapy. in Journal of nephrology / J Nephrol. 2023 Nov;36(8):2223-2231. doi: 10.1007/s40620-023-01636-6. Epub 2023 Jun 12.

2023
ASL Città di Torino

Sciascia S; Fenoglio R; Quattrocchio G; Roccatello D; Careddu A; Naretto C; Ferro M;

Identifying subsets of patients with undifferentiated connective tissue disease: Results from a prospective, real-world experience using particle-based multi-analyte technology. in Autoimmunity reviews / Autoimmun Rev. 2023 May;22(5):103298. doi: 10.1016/j.autrev.2023.103298. Epub 2023 Feb 14.

2023
ASL Città di Torino

Sciascia S; Roccatello D; Menegatti E; Bentow C; Rossi D; Mahler M; Miraglia P; Arbrile M; Wilson Jones G; Barinotti A; Radin M; Cecchi I;

Prevalence and clinical significance of ANCA positivity in lupus nephritis: a case series of 116 patients and literature review. in Journal of nephrology / J Nephrol. 2023 May;36(4):1059-1070. doi: 10.1007/s40620-023-01574-3. Epub 2023 Mar 20.

2023
ASL Città di Torino

Moroni G; Minetti E; Roccatello D; Trezzi B; Sciascia S; Reggiani F; Pozzi MR; Radice A; Calatroni M; Roggero L; Lacetera R; Sinico RA;

ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2023 Mar;41(3):543-553. doi: 10.55563/clinexprheumatol/jpargp. Epub 2023 Mar 14.

2023
ASL Città di Torino

Smith V; Scirè CA; Simonini G; Sciascia S; Schneider M; Romão VC; Richez C; Rednic S; Pistello M; Pileckyte M; Pamfil C; Olesinska M; Nagy G; Moroncini G; Marinello D; Meyer A; Limper M; Khmelinskii N; Jacobsen S; Iaccarino L; Galetti I; Hachulla E; Fonseca JE; Faria R; Damian L; Della-Torre E; Cutolo M; Cervera R; Callens S; et alii...

Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of antiphospholipid syndrome: study protocol. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2023 Mar;41(3):597-604. doi: 10.55563/clinexprheumatol/qa2yb4. Epub 2022 Oct 28.

2023
ASL Città di Torino

Roccatello D; Menegatti E; Vaccarino A; Fenoglio R; Rossi D; Rubini E; Barinotti A; Cecchi I; Radin M; Sciascia S;

Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study. in RMD open / RMD Open. 2023 Jun;9(2):e002830. doi: 10.1136/rmdopen-2022-002830.

2023
ASL Città di Torino

Moiseev S; Campochiaro C; Vautier M; Muratore F; Boiardi L; Galli E; Alvarado M; Dellal A; Gaches F; Zeminsky P; Lo Gullo A; Mukuchyan V; Kuwana M; Baldissera EM; Tomelleri A; Woaye-Hune P; Humbert S; Koné-Paut I; Denis G; Audemard-Verger A; Belot A; Frikha F; Berthier S; Maurier F; Seguier J; Sené T; Dufrost V; Broner J; Hassold N; et alii...

Health inequalities and social determinants of health: The role of syndemics in rheumatic diseases. in Autoimmunity reviews / Autoimmun Rev. 2023 Jul;22(7):103351. doi: 10.1016/j.autrev.2023.103351. Epub 2023 Apr 28.

2023
ASL Città di Torino

Roccatello D; Husum D; Schreiber K; Radin M; Ricceri F; Sciullo A; Cioffi M; Padovan D; Sciascia S; Gilcrease GW; Nikiphorou E;

Autoantibodies testing in autoimmunity: Diagnostic, prognostic and classification value. in Autoimmunity reviews / Autoimmun Rev. 2023 Jul;22(7):103356. doi: 10.1016/j.autrev.2023.103356. Epub 2023 May 6.

2023
ASL Città di Torino

Papp M; Shoenfeld Y; Tornai D; Grossi C; Bossuyt X; Borghi MO; Dimitrios B; Meroni PL; Bizzaro N; Sciascia S; Ielo D; Fritzler MJ;

Reply to comment on: Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2023 Jan;41(1):197. doi: 10.55563/clinexprheumatol/g1a1u3. Epub 2022 Oct 13.

2023
ASL Città di Torino

Roccatello D; Sciascia S; Rossi D; Barinotti A; Foddai SG; Cecchi I; Rubini E; Radin M;

"How we treat" clinical dilemmas in antiphospholipid syndrome: A case-based approach. in European journal of internal medicine / Eur J Intern Med. 2023 Jan;107:1-6. doi: 10.1016/j.ejim.2022.10.010. Epub 2022 Oct 20.

2023
ASL Città di Torino

Sciascia S; Roccatello D; Pengo V; Morotti A; Rubini E; Barinotti A; Arbrile M; Foddai SG; Radin M; Cecchi I;

Finding the Needle in the Haystack: Serological and Urinary Biomarkers in Behçet's Disease: A Systematic Review. in International journal of molecular sciences / Int J Mol Sci. 2023 Feb 3;24(3):3041. doi: 10.3390/ijms24033041.

2023
ASL Città di Torino

Roccatello D; Menegatti E; Barinotti A; Foddai SG; Rilat L; Cecchi I; Miraglia P; Medica D; Arbrile M; Radin M; Sciascia S;

Refractory Systemic Lupus Erythematosus: Identification and Pharmacological Management. in Drugs / Drugs. 2023 Feb;83(2):117-134. doi: 10.1007/s40265-022-01824-x. Epub 2023 Feb 2.

2023
ASL Città di Torino

Fenoglio R; Rossi D; Sciascia S; Roccatello D;

The role of bacteria and viruses in Behçet syndrome: Should we move towards new paradigms? in Autoimmunity reviews / Autoimmun Rev. 2023 Feb;22(2):103237. doi: 10.1016/j.autrev.2022.103237. Epub 2022 Nov 19.

2023
ASL Città di Torino

Lembo D; Civra A; Radin M; Roccatello D; Trunfio M; Calcagno A; Arbrile M; Sciascia S;

Complement levels during the first trimester predict disease flare and adverse pregnancy outcomes in systemic lupus erythematosus: A network meta-analysis on 532 pregnancies. in Autoimmunity reviews / Autoimmun Rev. 2023 Dec;22(12):103467. doi: 10.1016/j.autrev.2023.103467. Epub 2023 Oct 17.

2023
ASL Città di Torino

Chighizola CB; Andreoli L; Sciascia S; Tamborini F; Roccatello D; Moroni G; Reyes-Navarro GV; Iaccarino L; Larosa M; Saavedra MÁ; Crisafulli F; Klumb EM; de Jesús GR; Lacerda MI; Radin M; Cecchi I;

Thrombin generation assay and lupus anticoagulant synergically distinguish populations of patients with antiphospholipid antibodies. in Journal of clinical pathology / J Clin Pathol. 2023 Dec;76(12):839-846. doi: 10.1136/jcp-2022-208199. Epub 2022 Sep 13.

2023
ASL Città di Torino

Sciascia S; Menegatti E; Roccatello D; Rubini E; Foddai SG; Cecchi I; Barinotti A; Radin M;

Daratumumab monotherapy for refractory lupus nephritis. in Nature medicine / Nat Med. 2023 Aug;29(8):2041-2047. doi: 10.1038/s41591-023-02479-1. Epub 2023 Aug 10.

2023
ASL Città di Torino

Sciascia S; Cozzi M; Del Vecchio G; De Simone E; Rossi D; Rubini E; Cecchi I; Naretto C; Roccatello D; Fenoglio R; Kamgaing J; Caniggia I;

Focal segmental glomerular sclerosis can be effectively treated using an intensive B-cell depletion therapy. in Clinical kidney journal / Clin Kidney J. 2022 Sep 12;16(8):1258-1264. doi: 10.1093/ckj/sfac207. eCollection 2023 Aug.

2023
ASL Città di Torino
ASL Biella
AOU Città della Salute di Torino

Cravero R; Roscini E; Roccatello D; Baffa A; Naretto C; Fenoglio R; Sciascia S; Barreca A;

Chasing the Zebra: a case of membranous-like Glomerulopathy with SSA/RO52 deposits and no overt connective tissue disease. in BMC rheumatology / BMC Rheumatol. 2023 Apr 5;7(1):6. doi: 10.1186/s41927-023-00330-1.

2023
AOU Città della Salute di Torino
ASL Città di Torino

Lanzetta I; Fenoglio R; Menegatti E; Roccatello D; Charbonier N; Barreca A; Cecchi I; Sciascia S; Giarin M; Radin M; Miraglia P;

Obstetric outcomes in women with rheumatic disease and COVID-19 in the context of vaccination status. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2023 Apr 3;62(4):1621-1626. doi: 10.1093/rheumatology/keac534.

2023
ASL Città di Torino

Machado PM; Yazdany J; Zepa J; Wise L; Worthing AB; Zell J; Werner ML; Wallace Z; Tissera Y; Strangfeld A; Sufka P; Tanner H; Sparks J; Sirotich E; Morales RS; Siddique F; Sencarova M; Sciascia S; Savio V; Ruderman E; Sattui S; Quintana R; Quiambao AL; Pons-Estel G; Pisoni C; Patel NJ; Pera M; Papagoras C; Padjen I; et alii...

Clinical-Pathological Characteristics of Renal Injuries Identify Different Clusters in Patients With Antiphospholipid Antibodies. in Kidney international reports / Kidney Int Rep. 2023 Jan 23;8(4):754-763. doi: 10.1016/j.ekir.2023.01.018. eCollection 2023 Apr.

2023
ASL Città di Torino
AOU Città della Salute di Torino

Barreca A; Caroti L; Roccatello D; Fenoglio R; Sciascia S; De Simone E; Cecchi I; Emmi G; Cuadrado MJ; Radin M; Becker JU; Seshan SV; Andrade D; Moroni G; Yazdany J; Innocenti S;

Undiagnosed diseases: Needs and opportunities in 20 countries participating in the Undiagnosed Diseases Network International. in Frontiers in public health / Front Public Health. 2023 Mar 2;11:1079601. doi: 10.3389/fpubh.2023.1079601. eCollection 2023.

2023
ASL Città di Torino

Shotelersuk V; Jamuar SS; Scaria V; Romero V; Puri RD; Melegh B; Ozbek U; Makay P; Landoure G; Kvlividze O; Hettiarachchi D; Gonzaga-Jauregui C; Giugliani R; Dissanayake VHW; Cutiongco-de la Paz EM; Baynam G; Cederroth H; Azam M; Alanay Y; Groft S; Sciascia S; Ferrari G; Carta C; Cellai LL; Lumaka A; Salvatore M; Taruscio D; Roccatello D; Gahl WA; et alii...

The need for kidney biopsy in the management of side effects of target and immunotherapy. in Frontiers in nephrology / Front Nephrol. 2023 Feb 27;3:1043874. doi: 10.3389/fneph.2023.1043874. eCollection 2023.

2023
ASL Città di Torino
AOU Città della Salute di Torino

Roccatello D; Barreca A; Sciascia S; Cozzi M; Del Vecchio G; Fenoglio R; Comandone A;

Unmet needs in countries participating in the undiagnosed diseases network international: an international survey considering national health care and economic indicators. in Frontiers in public health / Front Public Health. 2023 Sep 26;11:1248260. doi: 10.3389/fpubh.2023.1248260. eCollection 2023.

2023
ASL Città di Torino

Bodamer O; Taruscio D; Posada M; Shotelersuk V; Gahl WA; Wiafe SA; Jamuar SS; Scaria V; Romero VI; Melegh B; Ozbek U; Puri RD; Kvlividze O; Landoure G; Makay P; Hettiarachchi D; Gonzaga-Jauregui C; Alanay Y; Azam M; Baynam G; Cederroth H; Cutiongco-de la Paz EM; Dissanayake VHW; Giugliani R; Ferrari G; Groft S; Lumaka A; Cellai LL; Carta C; et alii...

Pursuing appropriateness in antiphospholipid antibodies testing: Feasibility study with a reflex test approach for anti-?2GPI I domain in Autoimmunity Reviews

2023
ASL Città di Torino

Infantino M; Foddai S; Manfredi M; Benucci M; Radin M; Cecchi I; Barinotti A; Aluf O; Rubini E; Elnaz R; Menegatti E; Roccatello D; Sciascia S;

REASONS FOR BREASTFEEDING AVOIDANCE: A MULTICENTER INSIGHT IN MOTHERS WITH SYSTEMIC LUPUS ERYTHEMATOSUS in Annals of the Rheumatic Diseases

2023
ASL Città di Torino

Foddai SG; Radin M; Schreiber K; Cecchi I; Signorelli F; De Jesùs G; Aso K; Kono M; Urban ML; Bacco B; Gallo Cassarino S; Lo Sardo L; Arbrile M; Barinotti A; Gómez-García I; Quaglia MI; Tissera Y; Gervaso F; Aguirre-Zamorano MÁ; Alba P; Benedetto C; Atsumi T; Amengual O; Emmi G; Andrade D; Marozio L; Roccatello D; Sciascia S;

Antiphospholipid Syndrome and Kidney Involvement. in Kidney & blood pressure research / Kidney Blood Press Res. 2023;48(1):666-677. doi: 10.1159/000529229. Epub 2023 Sep 21.

2023
AOU Città della Salute di Torino
ASL Città di Torino

Roccatello D; Barreca A; Fenoglio R; De Simone E; Sciascia S; Oddone V;

Assessing the cardiovascular risk in patients with systemic lupus erythematosus: QRISK and GAPSS scores head-to-head. in International journal of cardiology / Int J Cardiol. 2022 Sep 15;363:185-189. doi: 10.1016/j.ijcard.2022.06.040. Epub 2022 Jun 14.

2022
ASL Città di Torino

Sciascia S; Roccatello D; Menegatti E; Rubini E; Arbrile M; Foddai SG; Cecchi I; Radin M; Barinotti A;

Recognizing the new disorder "idiopathic hypocryoglobulinaemia" in patients with previously unidentified clinical conditions. in Scientific reports / Sci Rep. 2022 Sep 1;12(1):14904. doi: 10.1038/s41598-022-18427-x.

2022
ASL Città di Torino
AOU Città della Salute di Torino

Rossi D; Fenoglio R; Viziello L; Barreca A; Solfietti L; Battaglia L; Naretto C; Sciascia S; Roccatello D;

Erratum: Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS). in Thrombosis and haemostasis / Thromb Haemost. 2022 Sep;122(9):e1. doi: 10.1055/s-0043-1769787. Epub 2023 May 24.

2022
ASL Città di Torino

Truglia S; Urban ML; Sebastiani GD; Ramoni VL; Rubini E; Raffeiner B; Pazzola G; Radin M; Nalli C; Lazzaroni MG; Hoxha A; Larosa M; Gerosa M; Franceschini F; Fischetti F; Fioravanti A; Emmi G; Conti F; Chighizola CB; Cecchi I; Carubbi F; Canti V; Calligaro A; Barinotti A; Andreoli L; Alunno A; Alessandri C; Foddai SG; Sciascia S; et alii...

Pregnancy outcomes in Behçet's disease: Results from a monocentric cohort. in Journal of reproductive immunology / J Reprod Immunol. 2022 Sep;153:103682. doi: 10.1016/j.jri.2022.103682. Epub 2022 Aug 1.

2022
ASL Città di Torino

Sciascia S; Roccatello D; Menegatti E; Rossi D; Radin M; Arbrile M;

Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS). in Thrombosis and haemostasis / Thromb Haemost. 2022 Sep;122(9):1612-1620. doi: 10.1055/a-1798-2400. Epub 2022 Mar 15.

2022
ASL Città di Torino

Tincani A; Roccatello D; Urban ML; Sebastiani GD; Truglia S; Rubini E; Raffeiner B; Radin M; Ramoni VL; Nalli C; Pazzola G; Lazzaroni MG; Larosa M; Gerosa M; Hoxha A; Franceschini F; Fischetti F; Emmi G; Fioravanti A; Chighizola CB; Conti F; Cecchi I; Canti V; Carubbi F; Calligaro A; Andreoli L; Barinotti A; Alessandri C; Alunno A; et alii...

Extrahepatic Manifestations of Chronic HBV Infection and the Role of Antiviral Therapy. in Journal of clinical medicine / J Clin Med. 2022 Oct 23;11(21):6247. doi: 10.3390/jcm11216247.

2022
ASL Città di Torino

Roccatello D; Gattei V; Sciascia S; Fenoglio R; Andreone P; Serraino D; Zanier A; Nevola R; Pozzato G; Adinolfi LE; Mazzaro C;

Renal Fibrosis in Lupus Nephritis. in International journal of molecular sciences / Int J Mol Sci. 2022 Nov 18;23(22):14317. doi: 10.3390/ijms232214317.

2022
ASL Città di Torino

Roccatello D; Rossi D; Wilson Jones G; Mancardi D; Fenoglio R; Cecchi I; Radin M; Barinotti A; Cozzi M; Sciascia S;

Serum Biomarkers of Renal Fibrosis: A Systematic Review. in International journal of molecular sciences / Int J Mol Sci. 2022 Nov 16;23(22):14139. doi: 10.3390/ijms232214139.

2022
ASL Città di Torino

Sciascia S; Roccatello D; Rubini E; Foddai SG; Cecchi I; Radin M; Barinotti A;

Clinical and peculiar immunological manifestations of SARS-CoV-2 infection in systemic lupus erythematosus patients. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2022 May 5;61(5):1928-1935. doi: 10.1093/rheumatology/keab611.

2022
ASL Città di Torino
AOU Città della Salute di Torino

Caporali R; Roccatello D; Sinico RA; Miraglia P; Pregnolato F; Tamborini F; Argolini LM; Sciascia S; Moroni G; Schioppo T; Gerosa M;

Dickkopf Homolog 3 (DKK3) as a Prognostic Marker in Lupus Nephritis: A Prospective Monocentric Experience. in Journal of clinical medicine / J Clin Med. 2022 May 25;11(11):2977. doi: 10.3390/jcm11112977.

2022
ASL Città di Torino

Roccatello D; Fenoglio R; Baldovino S; Rossi D; Terzolo E; Menegatti E; Cecchi I; Radin M; Barinotti A; Sciascia S;

Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2022 Mar;40(3):575-580. doi: 10.55563/clinexprheumatol/7vp1bo. Epub 2021 Jun 26.

2022
ASL Città di Torino

Roccatello D; Sciascia S; Rossi D; Barinotti A; Foddai SG; Cecchi I; Rubini E; Radin M;

Pathogenesis-based new perspectives of management of ANCA-associated vasculitis. in Autoimmunity reviews / Autoimmun Rev. 2022 Mar;21(3):103030. doi: 10.1016/j.autrev.2021.103030. Epub 2021 Dec 29.

2022
ASL Città di Torino

Roccatello D; Ponticelli C; Sciascia S;

EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome. in Annals of the rheumatic diseases / Ann Rheum Dis. 2022 Jun;81(6):768-779. doi: 10.1136/annrheumdis-2021-221733. Epub 2022 Feb 2.

2022
ASL Città di Torino

Tektonidou MG; Nurmohamed MT; Ward MM; Macfarlane GJ; Voskuyl A; van Halm V; Tyndall A; Tausche AK; Szekanecz Z; Svenungsson E; Sciascia S; Schreiber K; Sattar N; Ramos-Casals M; Mukhtyar C; Marchiori F; Kerekes G; Jacobsen S; González-Gay MÁ; Bruce IN; Brodin N; Boumpas DT; Badreh S; Atzeni F; Boekel L; Houben E; Vedder D; Drosos GC;

Differentiating between UCTD and early-stage SLE: from definitions to clinical approach. in Nature reviews. Rheumatology / Nat Rev Rheumatol. 2022 Jan;18(1):9-21. doi: 10.1038/s41584-021-00710-2. Epub 2021 Nov 11.

2022
ASL Città di Torino

Pons-Estel G; Mosca M; Yazdany J; Parodis I; Roccatello D; Radin M; Sciascia S;

COVID-19 in Pregnant Women With Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance. in The Journal of rheumatology / J Rheumatol. 2022 Jan;49(1):110-114. doi: 10.3899/jrheum.210480. Epub 2021 Sep 1.

2022
ASL Città di Torino

Robinson PC; Strangfeld A; Clowse MEB; Yazdany J; Machado PM; Sufka P; Wallace ZS; Sirotich E; Sparks JA; Liew JW; Hyrich K; Lawson-Tovey S; Hausmann JS; Gossec L; Grainger R; Duarte-Garcia A; Worthing AB; Costello W; Zell J; Bhana S; Wise LM; Valenzuela-Almada MO; Siddique F; Sciascia S; Sattui SE; Patel NJ; Ruderman EM; McCarthy EM; Al Emadi S; et alii...

Quality of life measures in Systemic Lupus Erythematosus: A systematic review. in Reumatismo / Reumatismo. 2022 Feb 7;73(4). doi: 10.4081/reumatismo.2021.1447.

2022
ASL Città di Torino

Uthman I; Taher A; Roccatello D; Barinotti A; Radin M; El Hasbani G; Sciascia S;

Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study. in Annals of the rheumatic diseases / Ann Rheum Dis. 2022 Dec;81(12):1769-1772. doi: 10.1136/ard-2022-222776. Epub 2022 Jul 18.

2022
ASL Città di Torino

Emmi G; Prisco D; Vaglio A; Jayne D; Sciascia S; Roccatello D; Parronchi P; André M; Moi L; Schroeder J; Solans R; Flossmann O; Padoan R; Franceschini F; Folci M; Bargagli E; Negrini S; Caminati M; Dagna L; Egan A; Iannone F; Lopalco G; Mattioli I; Fiori D; Bello F; Bettiol A; Urban ML;

Disease activity at conception predicts lupus flare up to two years after birth: A multicentre long term follow-up study. in Seminars in arthritis and rheumatism / Semin Arthritis Rheum. 2022 Dec;57:152113. doi: 10.1016/j.semarthrit.2022.152113. Epub 2022 Oct 22.

2022
AO Ordine Mauriziano
ASL Città di Torino

Sciascia S; Roccatello D; Marozio L; Andrade D; Emmi G; Amengual O; Atsumi T; Benedetto C; Alba P; Aguirre-Zamorano MÁ; Gervasoni F; Tissera Y; Quaglia MI; Gómez-García I; Barinotti A; Foddai SG; Lo Sardo L; Gallo Cassarino S; Bacco B; Urban ML; Kono M; Aso K; de Jesús G; Signorelli F; Cecchi I; Schreiber K; Radin M;

Air Pollution from Global Health to Individual Risk Factor-Is It Time for Enviropathies in Everyday Clinical Practice? in International journal of environmental research and public health / Int J Environ Res Public Health. 2022 Aug 4;19(15):9595. doi: 10.3390/ijerph19159595.

2022
ASL Torino 4
ASL Città di Torino

Ricceri F; Peano C; Padovan D; Gilcrease GW; Roccatello L; Sciascia S;

Chronic glucocorticoid maintenance treatment is associated with the risk of SARS-CoV-2 infection in patients with systemic lupus erythematosus who received vaccination. in Annals of the rheumatic diseases / Ann Rheum Dis. 2022 Aug 3:annrheumdis-2022-222832. doi: 10.1136/ard-2022-222832.

2022
ASL Città di Torino

Gerosa M; Caporali R; Bozzolo EP; Roccatello D; Beretta L; Bellocchi C; Miraglia P; Mescia F; Tamborini F; Moroni G; Sinico RA; Bonelli G; Alberici F; Moroni L; Sciascia S; Schioppo T; Argolini LM; Ramirez GA; Dagna L;

Detection of Autoantibodies in Saliva as New Avenue for the Diagnosis and Management of Autoimmune Patients. in Diagnostics (Basel, Switzerland) / Diagnostics (Basel). 2022 Aug 22;12(8):2026. doi: 10.3390/diagnostics12082026.

2022
ASL Città di Torino

Mahler M; Roccatello D; Foddai S; Cecchi I; Barinotti A; Radin M; Bentow C; Sciascia S;

Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTOR App. in International journal of environmental research and public health / Int J Environ Res Public Health. 2022 Apr 28;19(9):5379. doi: 10.3390/ijerph19095379.

2022
ASL Città di Torino

Sciascia S; Roccatello D; Rossi D; Menegatti E; Baldovino S; Barinotti A; Favuzzi MD; Crosasso P; Milone V; Osella S; Di Gregorio F; Di Nunzio P; Buccarano N; Arbrile M; Cecchi I; Radin M;

The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study. in Vaccines / Vaccines (Basel). 2022 Apr 22;10(5):663. doi: 10.3390/vaccines10050663.

2022
ASL Città di Torino

Caporali R; Bozzolo E; Dagna L; Roccatello D; Beretta L; Bellocchi C; Miraglia P; Tamborini F; Moroni L; Mescia F; Alberici F; Bonelli G; Sinico RA; Moroni G; Ramirez GA; Sciascia S; Argolini LM; Schioppo T; Gerosa M;

Efficacy and safety of TNF-? antagonists and tocilizumab in Takayasu arteritis: multicentre retrospective study of 209 patients. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2022 Apr 11;61(4):1376-1384. doi: 10.1093/rheumatology/keab635.

2022
ASL Città di Torino

Galli E; Zeminsky P; Gaches F; Lo Gullo A; Kuwana M; Baldissera E; Tomelleri A; Woaye-Hune P; Humbert S; Kone Pault I; Audemard-Verger A; Denis G; Frikha F; Belot A; Berthier S; Maurier F; Seguier J; Sene T; Dufrost V; Broner J; Hassold N; Sacre K; Lioger B; Goulenok T; Jego P; Perlat A; Benhamou Y; Le Mouel E; Gaultier JB; et alii...

Efficacy and safety of TNF-? antagonists and tocilizumab in Takayasu arteritis: multicentre retrospective study of 209 patients. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2022 Apr 11;61(4):1376-1384. doi: 10.1093/rheumatology/keab635.

2022
ASL Città di Torino

Vautier M; Boiardi L; Muratore F; Alvarado M; Galli E; Zeminsky P; Gaches F; Lo Gullo A; Kuwana M; Baldissera E; Tomelleri A; Woaye-Hune P; Humbert S; Kone Pault I; Audemard-Verger A; Denis G; Frikha F; Berthier S; Belot A; Maurier F; Sene T; Seguier J; Dufrost V; Broner J; Hassold N; Lioger B; Sacre K; Goulenok T; Jego P; et alii...

SAFETY and EFFICACY of the INTENSIFIED B CELL DEPLETION INDUCTION THERAPY for PATIENTS with ANCA-ASSOCIATED VASCULITIS and SEVERE RENAL INJURY: A CONTROLLED STUDY in Annals of the Rheumatic Diseases

2022
AOU Città della Salute di Torino
ASL Città di Torino

Roccatello D; Sciascia S; Murgia S; Quattrocchio G; Ferro M; De Simone E; Naretto C; Barreca A; Rossi D; Fenoglio R;

Renal Involvement in Transthyretin Amyloidosis: The Double Presentation of Transthyretin Amyloidosis Deposition Disease. in Nephron / Nephron. 2022;146(5):481-488. doi: 10.1159/000522370. Epub 2022 Mar 18.

2022
ASL Città di Torino

Roccatello D; Papotti M; Sbaiz L; Sciascia S; Bottasso E; Barreca A; Baldovino S; Fenoglio R;

Non HCV-Related Mixed Cryoglobulinemic Vasculitis With Biopsy-Proven Renal Involvement: The Effects of Rituximab. in Frontiers in medicine / Front Med (Lausanne). 2022 Mar 28;9:819320. doi: 10.3389/fmed.2022.819320. eCollection 2022.

2022
ASL Città di Torino

Roccatello D; Alpa M; Naretto C; Rossi D; Sciascia S; Fenoglio R;

How the Availability of Anti-C5a Agents Could Change the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. in Kidney & blood pressure research / Kidney Blood Press Res. 2022;47(8):506-513. doi: 10.1159/000525357. Epub 2022 Jun 3.

2022
ASL Città di Torino

Sciascia S; Oddone V; Fenoglio R; Roccatello D;

Editorial: Clinical, Molecular and Adverse Responses to B-Cell Therapies in Autoimmune Disease. in Frontiers in immunology / Front Immunol. 2022 Jul 6;13:962088. doi: 10.3389/fimmu.2022.962088. eCollection 2022.

2022
ASL Città di Torino

Karim MY; Parodis I; Sciascia S;

Antiphospholipid antibodies are persistently positive at high titers. Additive value of platelet-bound C4d. in Frontiers in immunology / Front Immunol. 2022 Aug 10;13:949919. doi: 10.3389/fimmu.2022.949919. eCollection 2022.

2022
ASL Città di Torino

Alexander RV; Kammesheidt A; O'Malley T; Bloch R; Sciascia S;

Circulating immune-complexes of IgG/IgM bound to B2-glycoprotein-I associated with complement consumption and thrombocytopenia in antiphospholipid syndrome. in Frontiers in immunology / Front Immunol. 2022 Sep 12;13:957201. doi: 10.3389/fimmu.2022.957201. eCollection 2022.

2022
ASL Città di Torino

Serrano A; Pleguezuelo D; Serrano M; Shoenfeld Y; Benucci M; Cecchi I; Radin M; Roccatello D; Saponjski J; Regola F; Stanisavljevic N; Milanovic M; Manfredi M; Garcinuño S; Kostyra-Grabczak K; Infantino M; Sciascia S; Ma?li?ska M; Tincani A; Djokovic A; Andreoli L; Naranjo L; Stojanovich L;

New Onset Biopsy-Proven Nephropathies after COVID Vaccination. in American journal of nephrology / Am J Nephrol. 2022;53(4):325-330. doi: 10.1159/000523962. Epub 2022 Mar 30.

2022
ASL Città di Torino

Roccatello D; Sciascia S; Del Vecchio G; De Simone E; Oddone V; Marchisio M; Lalloni S; Fenoglio R;

Renal involvement as a unique manifestation of hemophagocytic syndrome. in Frontiers in medicine / Front Med (Lausanne). 2022 Oct 5;9:796121. doi: 10.3389/fmed.2022.796121. eCollection 2022.

2022
ASL Città di Torino
AOU Città della Salute di Torino

Fenoglio R; Radin M; Quattrocchio G; Naretto C; Alpa M; Barreca A; Sciascia S; Roccatello D;

Treating Patients With ANCA-Associated Vasculitis and Very Severe Renal Injury With an Intensified B Cell Depletion Therapy: Comparison With a Control Cohort Receiving a Conventional Therapy. in Frontiers in immunology / Front Immunol. 2022 Mar 24;13:777134. doi: 10.3389/fimmu.2022.777134. eCollection 2022.

2022
ASL Città di Torino
AOU Città della Salute di Torino

Rossi D; De Simone E; Naretto C; Barreca A; Sammartino A; Roccatello D; Sciascia S; Murgia S; Quattrocchio G; Fenoglio R; Ferro M;

THE IMPACT of ANTI-SARS-COV-2 VACCINES in A MULTICENTER COHORT STUDY of PATIENTS with SYSTEMIC LUPUS ERYTHEMATOSUS in Annals of the Rheumatic Diseases

2022
ASL Città di Torino

Gerosa M; Schioppo T; Argolini LM; Sciascia S; Ramirez GA; Moroni G; Sinico RA; Alberici F; Moroni L; Tamborini F; Miraglia P; Bellocchi C; Beretta L; Roccatello D; Dagna L; Bozzolo E; Caporali R;

SEQUENTIAL RITUXIMAB and MEPOLIZUMAB in EOSINOPHILIC GRANULOMATOSIS with POLYANGIITIS in Annals of the Rheumatic Diseases

2022
ASL Città di Torino

Bettiol A; Urban ML; Bello F; Fiori D; Mattioli I; Lopalco G; Iannone F; Egan A; Moroni L; Dagna L; Caminati M; Negrini S; Cameli P; Folci M; Toniati P; Padoan R; Flossmann O; Solans-Laqué R; Losappio L; Schroeder J; André M; Moi L; Parronchi P; Conti F; Sciascia S; Jayne D; Vaglio A; Emmi G;

The global antiphospholipid syndrome score in women with systemic lupus erythematosus and adverse pregnancy outcomes. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2021 Sep-Oct;39(5):1071-1076. doi: 10.55563/clinexprheumatol/c96ief. Epub 2020 N

2021
ASL Città di Torino

Sciascia S; Cuadrado MJ; Jacobsen S; Roccatello D; Rubini E; Cecchi I; Radin M; Schreiber K;

Psychosocial burden in young patients with primary anti-phospholipid syndrome: an Italian nationwide survey (The AQUEOUS study). in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2021 Sep-Oct;39(5):938-946. doi: 10.55563/clinexprheumatol/2b73dn. Epub 2020 Sep

2021
ASL Città di Torino
AOU Città della Salute di Torino

Alunno A; Quartuccio L; Ramoni V; Bellis E; Sainaghi PP; Sciascia S; Pregnolato F; Coletto LA; Praino E; Radin M; Costa L; Baldi C; Monti S; Bellan M; Carubbi F; Hoxha A; Gerosa M; Crisafulli F; Chighizola CB; Andreoli L;

Clinical exome sequencing is a powerful tool in the diagnostic flow of monogenic kidney diseases: an Italian experience. in Journal of nephrology / J Nephrol. 2021 Oct;34(5):1767-1781. doi: 10.1007/s40620-020-00898-8. Epub 2020 Nov 23.

2021
ASL Cuneo 1
ASL Torino 4
AO Ordine Mauriziano
ASL Alessandria
AOU San Luigi di Orbassano
ASL VCO
AOU Città della Salute di Torino
ASL Torino 3
ASL Città di Torino

Amoroso A; Deaglio S; Roccatello D; Ungari S; Cantaluppi V; Chiappero F; Borzumati M; Bussolino S; Savoldi S; Biancone L; Vitale C; Calabrese G; Tamagnone M; Rendine S; Sciascia S; Fenoglio R; Rollino C; Baldovino S; Benvenuta C; Cocchi E; Pelle A; Togliatto G; Giachino D; Vanzino SB; Arruga F; Bracciamà V; Vaisitti T; Sorbini M; Kalantari S; et alii...

Quality of life in patients with antiphospholipid antibodies differs according to antiphospholipid syndrome damage index (DIAPS). in European journal of internal medicine / Eur J Intern Med. 2021 Oct;92:134-136. doi: 10.1016/j.ejim.2021.07.004. Epub 2021 Jul 28.

2021
ASL Città di Torino

Sciascia S; Roccatello D; Cecchi I; Foddai SG; Radin M;

A toggle switch linking coagulation and innate immunity in antiphospholipid antibody syndrome. in Kidney international / Kidney Int. 2021 Oct;100(4):740-742. doi: 10.1016/j.kint.2021.06.027. Epub 2021 Jun 30.

2021
ASL Città di Torino

Sciascia S; Roccatello D;

Clinical manifestations in patients with antiphospholipid antibodies: Beyond thrombosis and pregnancy loss. in Lupus / Lupus. 2021 May;30(6):884-892. doi: 10.1177/0961203321995248. Epub 2021 Feb 16.

2021
ASL Città di Torino

Roccatello D; Barinotti A; Foddai SG; Rubini E; Radin M; Cecchi I; Sciascia S;

Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome). in The European respiratory journal / Eur Respir J. 2021 May 6;57(5):2004158. doi: 10.1183/13993003.04158-2020. Print 2021 May.

2021
AO Ordine Mauriziano
AO Cuneo
AOU Città della Salute di Torino
ASL Città di Torino

Vaglio A; Emmi G; Olivotto I; Willeit P; Prisco D; Palmisano A; Dejaco C; Willeit J; Kiechl S; Maritati F; Pellecchio M; Marvisi C; Tomietto P; Bond M; Pazzola G; Tedesco M; Gabrielli A; Priori R; Cauli A; Padula A; Jeannin G; Bortolotti R; Racanelli V; Badiu I; Rolla G; Venerito V; Berti A; Iannone F; Bortoluzzi A; et alii...

Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2021 Mar 2;60(3):1106-1113. doi: 10.1093/rheumatology/kez596.

2021
AOU Città della Salute di Torino
ASL Città di Torino
AO Ordine Mauriziano

Mengozzi G; Roccatello D; Rossi D; Giachino O; Baldovino S; Vaccarino A; Bazzan M; Rubini E; Bertero MT; Bertolaccini ML; Cecchi I; Sciascia S; Radin M;

Reducing the diagnostic delay in Antiphospholipid Syndrome over time: a real world observation. in Orphanet journal of rare diseases / Orphanet J Rare Dis. 2021 Jun 16;16(1):280. doi: 10.1186/s13023-021-01906-1.

2021
ASL Città di Torino

Roccatello D; Sciascia S; Rubini E; Barinotti A; Cecchi I; Foddai SG; Radin M;

Improving the clinical accuracy in patients with antiphospholipid antibodies using anti-phosphatidylserine/prothrombin and anti-beta2 glycoprotein I domain and particle-based multi-analyte technology. in Thrombosis research / Thromb Res. 2021 Jun;202:100-103. doi: 10.1016/j.thromres.2021.03.019. Epub 2021 Mar 22.

2021
ASL Città di Torino

Sciascia S; Casas S; Roccatello D; Mahler M; Seaman A; Ramirez C; Barinotti A; Rubini E; Cecchi I; Radin M; Foddai S;

The role of antirheumatics in patients with COVID-19. in The Lancet. Rheumatology / Lancet Rheumatol. 2021 Jun;3(6):e447-e459. doi: 10.1016/S2665-9913(21)00062-X. Epub 2021 Mar 30.

2021
ASL Città di Torino

Sciascia S; de Andrade D; Nissen CB; Atsumi T; Bruce IN; Cron RQ; Hendricks O; Roccatello D; Stach K; Trunfio M; Vinet É; Schreiber K;

A new challenge for lupus nephritis management: Induction therapy without immunosuppressive maintenance regimen. in Autoimmunity reviews / Autoimmun Rev. 2021 Jul;20(7):102844. doi: 10.1016/j.autrev.2021.102844. Epub 2021 May 7.

2021
ASL Città di Torino

Rossi D; Fenoglio R; Sciascia S; Roccatello D;

16th International congress on antiphospholipid antibodies task force report on clinical manifestations of antiphospholipid syndrome. in Lupus / Lupus. 2021 Jul;30(8):1314-1326. doi: 10.1177/09612033211020361. Epub 2021 May 27.

2021
ASL Città di Torino

Erkan D; Levy RA; Cecchi I; Radin M; Sciascia S;

Community Garden Initiatives Addressing Health and Well-Being Outcomes: A Systematic Review of Infodemiology Aspects, Outcomes, and Target Populations. in International journal of environmental research and public health / Int J Environ Res Public Health. 2021 Feb 17;18(4):1943. doi: 10.3390/ijerph18041943.

2021
ASL Città di Torino

Peano C; Sottile F; Ghisalberti C; Sciascia S; Gregis A;

Endothelial dysfunction and cardiovascular risk in lupus nephritis: New roles for old players? in European journal of clinical investigation / Eur J Clin Invest. 2021 Feb;51(2):e13441. doi: 10.1111/eci.13441. Epub 2020 Nov 15.

2021
ASL Città di Torino

Roccatello D; Fenoglio R; Cecchi I; Radin M; Cozzi M; Arrigo E; Mancardi D; Sciascia S;

Health Disparities in Rheumatic Diseases: Understanding Global Challenges in Africa, Europe, Latin America, and Asia and Proposing Strategies for Improvement. in Rheumatic diseases clinics of North America / Rheum Dis Clin North Am. 2021 Feb;47(1):119-132. doi: 10.1016/j.rdc.2020.09.009.

2021
ASL Città di Torino

Shen N; Ding H; Pons-Estel GJ; Dey D; Sciascia S;

Impact of the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus in a Multicenter Cohort Study of 133 Women With Undifferentiated Connective Tissue Disease. in Arthritis care & research / Arthritis Care Res (Hoboken). 2021 Dec;73(12):1804-1808. doi: 10.1002/acr.24391. Epub 2021 Oct 4.

2021
ASL Città di Torino
AOU Città della Salute di Torino
AO Ordine Mauriziano

Bertero T; Govoni M; Benedetto C; Andrade D; Franceschini F; Gallo Cassarino S; Padovan M; Foddai SG; Rubini E; Bacco B; de Freitas CM; Crisafulli F; Bortoluzzi A; Cecchi I; Radin M; Schreiber K; Marozio L; Roccatello D; Andreoli L; Sciascia S;

Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies. in The Lancet. Rheumatology / Lancet Rheumatol. 2021 Dec;3(12):e832. doi: 10.1016/S2665-9913(21)00320-9. Epub 2021 Oct 20.

2021
ASL Città di Torino

Cecchi I; Baldovino S; Vaccarino A; Pini M; Schreiber K; Costanzo P; Radin M; Sciascia S; Roccatello D;

Moving toward personalized approaches in the management of lupus nephritis. in Expert opinion on biological therapy / Expert Opin Biol Ther. 2021 Dec;21(12):1547-1550. doi: 10.1080/14712598.2022.1998449. Epub 2021 Nov

2021
ASL Città di Torino

Roccatello D; Fenoglio R; Sciascia S;

The effect of hydroxychloroquine on platelet activation in model experiments. in Journal of thrombosis and thrombolysis / J Thromb Thrombolysis. 2021 Aug;52(2):674-679. doi: 10.1007/s11239-020-02325-y. Epub 2021 Jan 2.

2021
ASL Città di Torino

Stach K; Krämer BK; Leipe J; Weiß C; Schreiber K; Sciascia S; Wehrmann F;

Antiphospholipid antibodies and cerebrovascular thrombosis in the pediatric population: Few answers to many questions. in Lupus / Lupus. 2021 Aug;30(9):1365-1377. doi: 10.1177/09612033211021488. Epub 2021 Jun 4.

2021
ASL Città di Torino

Uthman I; Sciascia S; Sunji N; Taher AT; Hasbani GE;

Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies. in Immunologic research / Immunol Res. 2021 Aug;69(4):372-377. doi: 10.1007/s12026-021-09208-1. Epub 2021 Jul 10.

2021
ASL Città di Torino

Sciascia S; Menegatti E; Roccatello D; Rubini E; Cecchi I; Barinotti A; Foddai SG; Radin M;

Efficacy of low or standard rituximab-based protocols and comparison to Ponticelli's regimen in membranous nephropathy. in Journal of nephrology / J Nephrol. 2021 Apr;34(2):565-571. doi: 10.1007/s40620-020-00781-6. Epub 2020 Jun 27.

2021
ASL Città di Torino

Roccatello D; Naretto C; Quattrocchio G; Ferro M; Del Vecchio G; De Simone E; Sciascia S; Baldovino S; Fenoglio R;

Cryoglobulinemic glomerulonephritis: clinical presentation and histological features, diagnostic pitfalls and controversies in the management. State of the art and the experience on a large monocentric cohort treated with B cell depletion therapy. in Minerva medica / Minerva Med. 2021 Apr;112(2):162-174. doi: 10.23736/S0026-4806.20.07076-7. Epub 2020 Nov 16.

2021
AOU Città della Salute di Torino
ASL Città di Torino

Barreca A; Roccatello D; Solfietti L; Viziello L; Kalikatzaros I; Ventrella F; Baldovino S; Kamgaing J; Ferro M; Fenoglio R; Sciascia S; Rossi D;

Utilizing type I interferon expression in the identification of antiphospholipid syndrome subsets. in Expert review of clinical immunology / Expert Rev Clin Immunol. 2021 Apr;17(4):395-406. doi: 10.1080/1744666X.2021.1901581. Epub 2021 Mar 3

2021
ASL Città di Torino

Sciascia S; Knight JS; Tambralli A; Rodríguez-Carrio J; Radin M; Cecchi I;

A Prospective Study on Long-Term Clinical Outcomes of Patients With Lupus Nephritis Treated With an Intensified B-Cell Depletion Protocol Without Maintenance Therapy. in Kidney international reports / Kidney Int Rep. 2021 Feb 3;6(4):1081-1087. doi: 10.1016/j.ekir.2021.01.027. eCollection 2021 Apr.

2021
ASL Città di Torino

Rossi D; Rahbani E; Rubini E; Quattrocchio G; Ferro M; Fenoglio R; Alpa M; Naretto C; Sciascia S; Roccatello D;

The Challenging Management of Cancer: An Immunonephrologist's Perspective. in Kidney & blood pressure research / Kidney Blood Press Res. 2021;46(1):114-120. doi: 10.1159/000511256. Epub 2020 Dec 16.

2021
AOU Città della Salute di Torino
ASL Città di Torino

Barreca A; Sciascia S; Quattrocchio G; Ferro M; Del Vecchio G; Roccatello D; De Simone E; Fenoglio R;

Incidence of a First Thrombo-Embolic Event in Patients With Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies: A Prospective Study. in Frontiers in medicine / Front Med (Lausanne). 2021 Feb 1;8:621590. doi: 10.3389/fmed.2021.621590. eCollection 2021.

2021
ASL Città di Torino

Roccatello D; Vaccarino A; Rossi D; Barinotti A; Foddai SG; Rubini E; Cecchi I; Radin M; Sciascia S;

The global antiphospholipid syndrome score in women with systemic lupus erythematosus and adverse pregnancy outcomes in Clinical and Experimental Rheumatology

2021
ASL Città di Torino

Sciascia S; Cuadrado MJ; Jacobsen S; Roccatello D; Cecchi I; Rubini E; Schreiber K; Radin M;

Prognostic and Diagnostic Values of Novel Serum and Urine Biomarkers in Lupus Nephritis: A Systematic Review. in American journal of nephrology / Am J Nephrol. 2021;52(7):559-571. doi: 10.1159/000517852. Epub 2021 Aug 13.

2021
ASL Città di Torino

Roccatello D; Fenoglio R; Barinotti A; Miraglia P; Radin M; Sciascia S;

Antiphospholipid Antibodies and Infection: Non Nova Sed Nove. in Frontiers in immunology / Front Immunol. 2021 Jun 16;12:687534. doi: 10.3389/fimmu.2021.687534. eCollection 2021.

2021
ASL Città di Torino
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Bacco B; Norbiato C; Bertero MT; Carignola R; Cosseddu D; Montaruli B; Bazzan M; Radin M; Sciascia S; Gallo Cassarino S; Roccatello D;

Vedolizumab for the Management of Refractory Behçet's Disease: From a Case Report to New Pieces of Mosaic in a Complex Disease. in Frontiers in immunology / Front Immunol. 2021 Oct 25;12:769785. doi: 10.3389/fimmu.2021.769785. eCollection 2021.

2021
ASL Città di Torino

Roccatello D; Sciascia S; Baldovino S; Menegatti E; Rossi D; Radin M; Arbrile M;

Improving diagnosis for rare diseases: the experience of the Italian undiagnosed Rare diseases network. in Italian journal of pediatrics / Ital J Pediatr. 2020 Sep 14;46(1):130. doi: 10.1186/s13052-020-00883-8.

2020
ASL Città di Torino

Sangiuolo F; Novelli G; Neri M; Ferlini A; Da Riol RM; Bembi B; Iatropoulos P; Daina E; Remuzzi G; Menegatti E; Sciascia S; Roccatello D; Baldovino S; Polizzi A; De Stefano MC; Floridia G; Salvatore M; Brancati F; Taruscio D;

A multicentre study of 244 pregnancies in undifferentiated connective tissue disease: maternal/fetal outcomes and disease evolution. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2020 Sep 1;59(9):2412-2418. doi: 10.1093/rheumatology/kez620.

2020
ASL Città di Torino
AOU Città della Salute di Torino
AO Ordine Mauriziano

Roccatello D; Marozio L; Bertero T; Govoni M; Benedetto C; Franceschini F; Andrade D; Gallo Cassarino S; Padovan M; Foddai SG; Rubini E; Bacco B; de Freitas CM; Crisafulli F; Bortoluzzi A; Schreiber K; Cecchi I; Radin M; Andreoli L; Sciascia S;

Beyond current concepts in anti-phospholipid syndrome: The 16th International Congress on Anti-phospholipid Antibodies (ICAPA) in Manchester. in Autoimmunity reviews / Autoimmun Rev. 2020 Sep;19(9):102615. doi: 10.1016/j.autrev.2020.102615. Epub 2020 Jul 11.

2020
ASL Città di Torino

Andreoli L; Meroni PL; Sciascia S; Chighizola CB;

Towards a novel target therapy for renal diseases related to plasma cell dyscrasias: The example of AL amyloidosis. in Autoimmunity reviews / Autoimmun Rev. 2020 Sep;19(9):102622. doi: 10.1016/j.autrev.2020.102622. Epub 2020 Jul 12.

2020
ASL Città di Torino

Sciascia S; Barreca A; Rossi D; Ferro M; Naretto C; Baldovino S; Fenoglio R; Roccatello D;

Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome. in Autoimmunity reviews / Autoimmun Rev. 2020 Oct;19(10):102641. doi: 10.1016/j.autrev.2020.102641. Epub 2020 Aug 13.

2020
ASL Città di Torino

Mahler M; Roccatello D; Menegatti E; Fenoglio R; Baldovino S; Foddai SG; Rubini E; Cecchi I; Casas S; Bentow C; Seaman A; Ramirez C; Radin M; Sciascia S;

Antiphospholipid Syndrome Is Still a Rare Disease-Estimated Prevalence in the Piedmont and Aosta Valley Regions of Northwest Italy: Comment on the Article by Duarte-García et al. in Arthritis & rheumatology (Hoboken, N.J.) / Arthritis Rheumatol. 2020 Oct;72(10):1774-1776. doi: 10.1002/art.41401. Epub 2020 Sep 6.

2020
ASL Città di Torino

Roccatello D; Rubini E; Cecchi I; Vaccarino A; Montaruli B; Montabone E; Carignola R; Bertero T; Bazzan M; Sciascia S; Radin M; Baldovino S;

The prevalence of antiphospholipid antibodies in women with late pregnancy complications and low-risk for chromosomal abnormalities. in Journal of thrombosis and haemostasis : JTH / J Thromb Haemost. 2020 Nov;18(11):2921-2928. doi: 10.1111/jth.15053. Epub 2020 Sep 21.

2020
ASL Città di Torino
AOU Città della Salute di Torino

Marozio L; Benedetto C; Donati Marello B; Roccatello D; Manetta T; Mengozzi G; Menegatti E; Barinotti A; Orpheu G; Rubini E; Gaito S; Cecchi I; Radin M; Foddai SG; Sciascia S;

Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2020 May-Jun;38(3):529-532. Epub 2020 May 1.

2020
ASL Città di Torino

Roccatello D; Oddone V; Osella S; Piccioni P; Radin M; Navarra M; Natale G; Milone V; Massara C; Manno E; Livigni S; Giusti M; Imperiale D; Imperiale G; Crosasso P; De Iaco F; Di Perri G; Eandi M; Fenoglio R; Cozzi M; Converso M; Cinnirella G; Boaro D; Boero R; Bonora S; Calcagno A; Cecchi I; Baldovino S; Rossi D; et alii...

Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTORApp-A Usability Study. in International journal of environmental research and public health / Int J Environ Res Public Health. 2020 May 15;17(10):3469. doi: 10.3390/ijerph17103469.

2020
ASL Città di Torino

Rossi D; Roccatello D; Baldovino S; Foddai SG; Rubini E; Crosasso P; Favuzzi MD; Osella S; Valeria M; Di Gregorio F; Buccarano N; Di Nunzio P; Cecchi I; Radin M; Sciascia S;

Rituximab in severe immunoglobulin-A vasculitis (Henoch-Schönlein) with aggressive nephritis. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2020 Mar-Apr;38 Suppl 124(2):195-200. Epub 2020 May 22.

2020
ASL Città di Torino

Roccatello D; Quattrocchio G; Ferro M; Del Vecchio G; De Simone E; Naretto C; Sciascia S; Fenoglio R;

Filling the gap in antiphospholipid syndrome diagnosis: a patient's story. in Lupus / Lupus. 2020 Mar;29(3):236-238. doi: 10.1177/0961203320903810. Epub 2020 Jan 29.

2020
ASL Città di Torino

Roccatello D; Baldovino S; Radin M; Sciascia S;

CD38 and Anti-CD38 Monoclonal Antibodies in AL Amyloidosis: Targeting Plasma Cells and beyond. in International journal of molecular sciences / Int J Mol Sci. 2020 Jun 10;21(11):4129. doi: 10.3390/ijms21114129.

2020
ASL Città di Torino
AOU Città della Salute di Torino

Malavasi F; Baldovino S; Barreca A; Ferro M; Rossi D; Naretto C; Sciascia S; Fenoglio R; Roccatello D;

Pregnancy success rate and response to heparins and/or aspirin differ in women with antiphospholipid antibodies according to their Global AntiphosPholipid Syndrome Score. in Seminars in arthritis and rheumatism / Semin Arthritis Rheum. 2020 Jun;50(3):553-556. doi: 10.1016/j.semarthrit.2020.01.007. Epub 2020 Jan

2020
ASL Città di Torino

Cuadrado MJ; Sciascia S; Roccatello D; Rubini E; Schreiber K; Cecchi I; Radin M;

Global antiphospholipid syndrome score and anti-ß2-glycoprotein I domain I for thrombotic risk stratification in antiphospholipid syndrome: A four-year prospective study. in Lupus / Lupus. 2020 Jun;29(7):676-685. doi: 10.1177/0961203320916527. Epub 2020 Apr 11.

2020
ASL Città di Torino

de Andrade DCO; Sciascia S; Gândara APR; Radin M; Nascimento IS;

Hydroxychloroquine reduces IL-6 and pro-thrombotic status. in Autoimmunity reviews / Autoimmun Rev. 2020 Jul;19(7):102555. doi: 10.1016/j.autrev.2020.102555. Epub 2020 May 12.

2020
ASL Città di Torino

Stach K; Krämer BK; Roccatello D; Radin M; Schreiber K; Sciascia S;

Is air pollution affecting the disease activity in patients with systemic lupus erythematosus? State of the art and a systematic literature review. in European journal of rheumatology / Eur J Rheumatol. 2020 Jan 1;7(1):31-34. doi: 10.5152/eurjrheum.2019.19141. Print 2020 Jan.

2020
ASL Città di Torino

Sciascia S; Radin M; Cuadrado MJ; Roccatello D; Massaglia S; Heffler E; Peano C; Padovan D; Gilcrease GW;

Thermography in systemic sclerosis patients and other rheumatic diseases: Diagnosis, disease activity assessment, and therapeutic monitoring. in Autoimmunity reviews / Autoimmun Rev. 2020 Feb;19(2):102449. doi: 10.1016/j.autrev.2019.102449. Epub 2019 Dec 12.

2020
ASL Città di Torino

Roccatello D; Menegatti E; Alba P; Escudero A; Foddai SG; Rubini E; Guiñazu F; Ladehesa PL; Radin M; Rossi D; Massara C; Cecchi I; Sciascia S;

Validation of the Particle-Based Multi-Analyte Technology for Detection of Anti-PhosphatidylSerine/Prothrombin Antibodies. in Biomedicines / Biomedicines. 2020 Dec 17;8(12):622. doi: 10.3390/biomedicines8120622.

2020
ASL Città di Torino

Sciascia S; Roccatello D; Mahler M; Seaman A; Ramirez C; Barinotti A; Rubini E; Foddai SG; Cecchi I; Radin M;

Genetic Factors in Antiphospholipid Syndrome: Preliminary Experience with Whole Exome Sequencing. in International journal of molecular sciences / Int J Mol Sci. 2020 Dec 15;21(24):9551. doi: 10.3390/ijms21249551.

2020
ASL Città di Torino

Menegatti E; Sciascia S; Roccatello D; Rubini E; Foddai SG; Cecchi I; Radin M; Barinotti A;

Treatment of antiphospholipid syndrome. in Clinical immunology (Orlando, Fla.) / Clin Immunol. 2020 Dec;221:108597. doi: 10.1016/j.clim.2020.108597. Epub 2020 Sep 19.

2020
ASL Città di Torino

Sciascia S; Menegatti E; Roccatello D; Barinotti A; Rubini E; Foddai SG; Radin M; Cecchi I;

Long-term effects of intensive B cell depletion therapy in severe cases of IgG4-related disease with renal involvement. in Immunologic research / Immunol Res. 2020 Dec;68(6):340-352. doi: 10.1007/s12026-020-09163-3. Epub 2020 Nov 10.

2020
ASL Città di Torino

Roccatello D; Sciascia S; Rollino C; Massara C; Del Vecchio G; Ferro M; Fenoglio R; Barreca A; Demarchi A; Quattrocchio G;

Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection. in Thrombosis research / Thromb Res. 2020 Dec;196:432-434. doi: 10.1016/j.thromres.2020.09.039. Epub 2020 Oct 8.

2020
ASL Città di Torino

Calcagno A; Di Perri G; Bonora S; Roccatello D; Lipani F; Sciascia S; Trentalange A; Gaviraghi A; Alcantarini C; Marinaro L; Cabodi D; Salvador E; Trunfio M;

Low ADAMTS 13 plasma levels are predictors of mortality in COVID-19 patients. in Internal and emergency medicine / Intern Emerg Med. 2020 Aug;15(5):861-863. doi: 10.1007/s11739-020-02394-0. Epub 2020 Jun 18.

2020
ASL Città di Torino
AO Ordine Mauriziano

Norbiato C; Roccatello D; Cosseddu D; Montaruli B; Sciascia S; Bazzan M;

Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis. in Journal of nephrology / J Nephrol. 2020 Aug;33(4):757-762. doi: 10.1007/s40620-019-00698-9. Epub 2020 Jan 23.

2020
ASL Città di Torino
ASL Torino 5

Roccatello D; Rubini E; Miraglia P; Besso L; Baldovino S; Rossi D; De Marchi A; Fenoglio R; Cecchi I; Sciascia S; Radin M;

Antiphosphatidylserine/Prothrombin Antibodies: An Update on Their Association with Clinical Manifestations of Antiphospholipid Syndrome. in Thrombosis and haemostasis / Thromb Haemost. 2020 Apr;120(4):592-598. doi: 10.1055/s-0040-1705115. Epub 2020 Mar 17.

2020
ASL Città di Torino

Sciascia S; Bertolaccini ML; Roccatello D; Schreiber K; Rubini E; Cecchi I; Foddai SG; Radin M;

Rituximab, Cyclophosphamide, and Corticosteroids for ANCA Vasculitis: The Good, the Bad, and the Ugly. in Kidney & blood pressure research / Kidney Blood Press Res. 2020;45(6):784-791. doi: 10.1159/000509608. Epub 2020 Oct 12.

2020
ASL Città di Torino

Sciascia S; Roccatello D; Fenoglio R;

Circulating microRNAs as potential biomarkers for monitoring the response to in vivo treatment with Rituximab in systemic lupus erythematosus patients in Autoimmunity Reviews

2020
ASL Città di Torino

Lopez-Pedrera C; Menegatti E; Roccatello D; Aguirre Zamorano MA; Patiño Trives AM; Perez-Sanchez L; Scudeler L; Barbarroja Puerto N; Arias de la Rosa I; Radin M; Sciascia S; Perez-Sanchez C; Cecchi I;

Percutaneous renal biopsy in frail and high-risk patients in Journal of the American Society of Nephrology

2020
ASL Città di Torino

Fenoglio R; Sciascia S; Roccatello D;

Early restoration of immune and vascular phenotypes in systemic lupus erythematosus and rheumatoid arthritis patients after B cell depletion. in Journal of cellular and molecular medicine / J Cell Mol Med. 2019 Sep;23(9):6308-6318. doi: 10.1111/jcmm.14517. Epub 2019 Jul 26.

2019
ASL Città di Torino

Collantes E; López-Pedrera C; Aguirre MÁ; Sciascia S; Roccatello D; Radin M; Castro MC; Escudero A; Ortega R; Ibáñez-Costa A; Arias de la Rosa I; Luque-Tévar M; Pérez-Sánchez L; Barbarroja N; Patiño-Trives AM; Cecchi I; Pérez-Sánchez C;

Translational validation of the Global Antiphospholipid Syndrome Score in patients with thrombotic APS. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2019 Oct 1;58(10):1870-1872. doi: 10.1093/rheumatology/kez166.

2019
ASL Città di Torino

López Pedrera C; Roccatello D; Collantes E; Sciascia S; Menegatti E; Barbarroja N; Pérez-Sánchez C; Aguirre MÁ; Rubini E; Cecchi I; Radin M; Arias de la Rosa I;

The potential role of SLE-key test in identifying patients with Systemic Lupus Erythematosus: Results from a prospective, real-world experience. in European journal of internal medicine / Eur J Intern Med. 2019 Oct;68:e12-e14. doi: 10.1016/j.ejim.2019.07.026. Epub 2019 Aug 2.

2019
ASL Città di Torino
AOU Città della Salute di Torino

Cecchi I; Mengozzi G; Roccatello D; Sciascia S; Radin M;

Pregnancy outcomes in mixed connective tissue disease: a multicentre study. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2019 Nov 1;58(11):2000-2008. doi: 10.1093/rheumatology/kez141.

2019
ASL Città di Torino

Sciascia S; Marozio L; Roccatello D; Benedetto C; Aguirre MA; Izmirly P; Buyon J; Khamashta M; Gibbone E; Andrade D; Caleiro T; Franceschini F; Andreoli L; Cecchi I; Cuadrado MJ; Schreiber K; Radin M;

Nailfold Capillaroscopy Patterns. in The Israel Medical Association journal : IMAJ

2019
ASL Città di Torino

Rossi D; Sciascia S; Roccatello D;

Anticoagulation in patients with concomitant lupus nephritis and thrombotic microangiopathy: a multicentre cohort study. in Annals of the rheumatic diseases / Ann Rheum Dis. 2019 Jul;78(7):1004-1006. doi: 10.1136/annrheumdis-2018-214559. Epub 2018 Dec 14.

2019
ASL Città di Torino

Roccatello D; Papotti M; Schreiber K; Barreca A; Cuadrado MJ; Aggarwal I; Radin M; Fenoglio R; Dall'Era M; Yazdany J; Sciascia S;

Long-term effect of B-cells depletion alone as rescue therapy for severe thrombocytopenia in primary antiphospholipid syndrome. in Seminars in arthritis and rheumatism / Semin Arthritis Rheum. 2019 Feb;48(4):741-744. doi: 10.1016/j.semarthrit.2018.04.001. Epub 2018 Apr

2019
ASL Città di Torino

Roccatello D; Bazzan M; Rubini E; Cecchi I; Radin M; Sciascia S;

The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort. in Seminars in arthritis and rheumatism / Semin Arthritis Rheum. 2019 Dec;49(3):464-468. doi: 10.1016/j.semarthrit.2019.04.009. Epub 2019 May

2019
ASL Città di Torino

Banzato A; Sevim E; Barbhaiya M; Efthymiou M; Mackie I; Bertolaccini ML; Andrade D; Rossi Gandara AP; Borges Gualhardo Vendramini M; Willis R; Gonzalez E; Lopez-Pedrera R; Atsumi T; Knight JS; Rodriguez E; Rodriguez-Pinto I; Petri M; Andreoli L; Fortin PR; Branch DW; Ramires de Jesús G; Cohen H; Belmont HM; Ji L; Meroni P; Ugarte A; Tektonidou MG; Pengo V; Erkan D; et alii...

Prevalence of Antiphospholipid Antibodies Negativisation in Patients with Antiphospholipid Syndrome: A Long-Term Follow-Up Multicentre Study. in Thrombosis and haemostasis / Thromb Haemost. 2019 Dec;119(12):1920-1926. doi: 10.1055/s-0039-1696687. Epub 2019 Oct 6.

2019
ASL Città di Torino

Aguirre Zamorano MÁ; Cecchi I; Sciascia S; Roccatello D; Schreiber K; Radin M; Cuadrado MJ;

Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study. in Frontiers in immunology / Front Immunol. 2019 Mar 5;10:376. doi: 10.3389/fimmu.2019.00376. eCollection 2019.

2019
ASL Città di Torino
AOU Città della Salute di Torino
AOU Novara

Mahler M; Vaccarino A; Ferro M; Baldovino S; Muccini E; Pergolini P; Mengozzi G; Montaruli B; Rolla R; Scotta A; Rubini E; Radin M; Cecchi I; Sciascia S; Menegatti E; Roccatello D;

IgG Anti-high-Density Lipoproteins Antibodies Discriminate Between Arterial and Venous Events in Thrombotic Antiphospholipid Syndrome Patients. in Frontiers in medicine / Front Med (Lausanne). 2019 Sep 26;6:211. doi: 10.3389/fmed.2019.00211. eCollection 2019.

2019
ASL Città di Torino

Roccatello D; Rodríguez-Carrio J; Suárez A; Rubini E; Radin M; Cecchi I; Sciascia S;

The cyclophosphamide-sparing role of an intensified b-cells depletion protocol in anca-associated vasculitis in Annals of the Rheumatic Diseases

2019
ASL Città di Torino

Roccatello D; Sciascia S; Fenoglio R; Rossi D;

Percutaneous native renal biopsy as a safe procedure in outpatient with systemic autoimmune diseases: A monocentric cohort in Nephrology Dialysis Transplantation

2019
ASL Città di Torino

Roccatello D; Fenoglio R; Sciascia S;

Efficacy of low or standard dose rituximab as compared to Ponticelli's regimen in membranous nephropathy in Nephrology Dialysis Transplantation

2019
ASL Città di Torino

Roccatello D; Fenoglio R; Sciascia S;

The cyclophosphamide-sparing effect of an intensified B-cells depletion protocol in ANCA-associated vasculitis: A case-control study in Nephrology Dialysis Transplantation

2019
ASL Città di Torino

Roccatello D; Fenoglio R; Sciascia S;

Membranous nephropathy: efficacy of low or standard rituximab-based protocols and comparison to the ponticelli regimen in Journal of the American Society of Nephrology

2019
ASL Città di Torino

Fenoglio R; Sciascia S; Roccatello D;

Autosomal dominant polycystic kidney disease (ADPKD): Optimization of the evaluation of total kidney volume in Journal of the American Society of Nephrology

2019
ASL Città di Torino

Fenoglio R; Sciascia S; Roccatello D;

Lung cancer and renal failure in Journal of the American Society of Nephrology

2019
ASL Città di Torino

Fenoglio R; Sciascia S; Roccatello D;

Thrombotic antiphospholipid syndrome. in Lupus / Lupus. 2018 Oct;27(1_suppl):21-27. doi: 10.1177/0961203318801686.

2018
ASL Città di Torino

Radin M; Sciascia S;

Prevalence and significance of anti-phosphatidylserine antibodies: A pooled analysis in 5992 patients. in Thrombosis research / Thromb Res. 2018 Oct;170:28-31. doi: 10.1016/j.thromres.2018.07.031. Epub 2018 Aug 2.

2018
ASL Città di Torino

Mahler M; Sciascia S; Roccatello D; Schreiber K; Rubini E; Cecchi I; Radin M;

Multifocal avascular osteonecrosis despite appropriate anticoagulation therapy in a patient with systemic lupus erythematosus and antiphospholipid syndrome. in BMJ case reports / BMJ Case Rep. 2018 Nov 1;2018:bcr2018225532. doi: 10.1136/bcr-2018-225532.

2018
ASL Città di Torino

Roccatello D; Sciascia S; Pérez Sánchez L; Cecchi I;

Can we treat systemic lupus erythematosus and other autoimmune diseases without oral steroids? in Expert review of clinical immunology / Expert Rev Clin Immunol. 2018 Nov;14(11):877-879. doi: 10.1080/1744666X.2018.1527219. Epub 2018 Oct

2018
ASL Città di Torino

Roccatello D; Cuadrado MJ; Enriquez Merayo E; Sciascia S;

Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab. in Annals of the rheumatic diseases / Ann Rheum Dis. 2018 Nov;77(11):1694-1695. doi: 10.1136/annrheumdis-2018-213496. Epub 2018 May 18.

2018
ASL Città di Torino

Roccatello D; Rossi D; Cecchi I; Radin M; Rubini E; Sciascia S;

Facilitated subcutaneous immunoglobulin treatment in pemphigus vulgaris. in BMJ case reports / BMJ Case Rep. 2018 May 30;2018:bcr2017223302. doi: 10.1136/bcr-2017-223302.

2018
ASL Città di Torino

Sciascia S; Baldovino S; Roccatello D; Radin M;

Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease. in Lupus

2018
ASL Città di Torino

Erkan D; Unlu O; Sciascia S; Belmont HM; Branch DW; Cuadrado MJ; Gonzalez E; Knight JS; Uthman I; Willis R; Zhang Z; Wahl D; Zuily S; Tektonidou MG;

Rituximab as a front-line therapy for adult-onset minimal change disease with nephrotic syndrome. in Oncotarget / Oncotarget. 2018 Jun 22;9(48):28799-28804. doi: 10.18632/oncotarget.25612. eCollection 2018 Jun 22.

2018
ASL Città di Torino

Roccatello D; Menegatti E; Ferro M; Quattrocchio G; Mesiano P; Beltrame G; Fenoglio R; Sciascia S;

Prevalence and Thrombotic Risk Assessment of Anti-?2 Glycoprotein I Domain I Antibodies: A Systematic Review. in Seminars in thrombosis and hemostasis / Semin Thromb Hemost. 2018 Jul;44(5):466-474. doi: 10.1055/s-0037-1603936. Epub 2017 Aug 4.

2018
ASL Città di Torino

Sciascia S; Meroni PL; Roccatello D; Cecchi I; Radin M;

Infodemiology of antiphospholipid syndrome: Merging informatics and epidemiology. in European journal of rheumatology / Eur J Rheumatol. 2018 Jul;5(2):92-95. doi: 10.5152/eurjrheum.2018.17105. Epub 2018 Jan 22.

2018
ASL Città di Torino

Sciascia S; Radin M; Unlu O; Erkan D; Roccatello D;

Safety of outpatient percutaneous native renal biopsy in systemic autoimmune diseases: results from a monocentric cohort. in Lupus / Lupus. 2018 Jul;27(8):1393-1394. doi: 10.1177/0961203317751645. Epub 2018 Jan 11.

2018
ASL Città di Torino

Menegatti E; Baldovino S; Sandrone M; Radin M; Solfietti L; Naretto C; Bazzan M; Rossi D; Sciascia S; Roccatello D;

Severe Multi-Organ Failure and Hypereosinophilia: When to Call It "Idiopathic"? in Journal of investigative medicine high impact case reports / J Investig Med High Impact Case Rep. 2018 Feb 15;6:2324709618758347. doi: 10.1177/2324709618758347.

2018
ASL Città di Torino

Sciascia S; Bertero L; Roccatello D; Radin M;

The risk of ischaemic stroke in primary antiphospholipid syndrome patients: a prospective study. in European journal of neurology / Eur J Neurol. 2018 Feb;25(2):320-325. doi: 10.1111/ene.13499. Epub 2017 Dec 2.

2018
ASL Città di Torino

Cuadrado MJ; Cecchi I; Roccatello D; Schreiber K; Radin M; Sciascia S;

Thymic stromal lymphopoietin in human pancreatic ductal adenocarcinoma: expression and prognostic significance. in Oncotarget / Oncotarget. 2018 Aug 28;9(67):32795-32809. doi: 10.18632/oncotarget.25997. eCollection 2018 Aug 28.

2018
ASL Città di Torino
AO Ordine Mauriziano
AOU Città della Salute di Torino

Cristiano C; Mazibrada J; Bosco O; Novarino A; Prati A; Sciascia S; Rolla G; Ciuffreda L; Montrucchio G; Bellone G; Boita M; Vizio B;

Extra-criteria manifestations of antiphospholipid syndrome: Risk assessment and management. in Seminars in arthritis and rheumatism / Semin Arthritis Rheum. 2018 Aug;48(1):117-120. doi: 10.1016/j.semarthrit.2017.12.006. Epub 2018 Jan

2018
ASL Città di Torino

Andrade D; Sciascia S; Ugolini-Lopes MR; Radin M;

Clinical utility of the global anti-phospholipid syndrome score for risk stratification: a pooled analysis. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2018 Apr 1;57(4):661-665. doi: 10.1093/rheumatology/kex466.

2018
ASL Città di Torino

Bertolaccini ML; Cecchi I; Roccatello D; Radin M; Sanna G; Sciascia S;

Recent advances in the management of systemic lupus erythematosus. in F1000Research / F1000Res. 2018 Jun 29;7:F1000 Faculty Rev-970. doi: 10.12688/f1000research.13941.1. eCollection 2018

2018
ASL Città di Torino

Sanna G; Bertolaccini ML; Roccatello D; Radin M; Sciascia S;

Reliability of lupus anticoagulant and anti-phosphatidylserine/prothrombin autoantibodies in antiphosphospholipid syndrome: A multicenter study in Arthritis and Rheumatology

2018
ASL Città di Torino
AOU Città della Salute di Torino

Radin M; Cecchi I; Rubini E; Scotta A; Rolla R; Montaruli B; Pergolini P; Mengozzi G; Muccini E; Vaccarino A; Roccatello D; Sciascia S; Batticciotto A; Prato G; Antivalle M; Ditto MC; Agosti M; Cumbo E; Talotta R; Atzeni F; Sarzi-Puttini P;

The cyclophosphamide-sparing role of an intensified b-cells depletion protocol in anca-associated vasculitis: A case-control study in Journal of the American Society of Nephrology

2018
ASL Città di Torino

Fenoglio R; Sciascia S; Roccatello D;

Clinical outcomes and response to anti-thrombotic treatment among patients with concomitant lupus nephritis and thrombotic microangiopathy: A multicentre cohort study in Journal of the American Society of Nephrology

2018
ASL Città di Torino

Sciascia S; Fenoglio R; Roccatello D;

Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances. in Nature reviews. Rheumatology

2017
ASL Città di Torino

Sciascia S; Amigo MC; Roccatello D; Khamashta M;

How I treat patients with systemic sclerosis in clinical practice. in Autoimmunity reviews / Autoimmun Rev. 2017 Oct;16(10):1024-1028. doi: 10.1016/j.autrev.2017.07.018. Epub 2017 Aug 1.

2017
ASL Città di Torino

Cozzi F; Roccatello D; Polito P; Sciascia S; Zanatta E; Marson P; Rossi D;

Can we withdraw anticoagulation in patients with antiphospholipid syndrome after seroconvertion? in Autoimmunity reviews / Autoimmun Rev. 2017 Nov;16(11):1109-1114. doi: 10.1016/j.autrev.2017.09.004. Epub 2017 Sep 9.

2017
ASL Città di Torino

Cervera R; Meroni PL; López-Pedrera C; Espinosa G; Bertolaccini ML; Coloma-Bazán E; Radin M; Sciascia S; Cuadrado MJ;

Autologous hematopoietic stem cell transplantation in Systemic Lupus Erythematosus and antiphospholipid syndrome: A systematic review. in Autoimmunity reviews / Autoimmun Rev. 2017 May;16(5):469-477. doi: 10.1016/j.autrev.2017.03.008. Epub 2017 Mar 7.

2017
ASL Città di Torino

Sciascia S; Roccatello D; Almarzooqi AM; Al-Saleh J; Radin M; Leone A; Khamashta M;

Efficacy of belimumab on renal outcomes in patients with systemic lupus erythematosus: A systematic review. in Autoimmunity reviews / Autoimmun Rev. 2017 Mar;16(3):287-293. doi: 10.1016/j.autrev.2017.01.010. Epub 2017 Jan 29.

2017
ASL Città di Torino

Sciascia S; Radin M; Yazdany J; Levy RA; Roccatello D; Dall'Era M; Cuadrado MJ;

Outpatient percutaneous native renal biopsy: safety profile in a large monocentric cohort. in BMJ open / BMJ Open. 2017 Jun 21;7(6):e015243. doi: 10.1136/bmjopen-2016-015243.

2017
ASL Città di Torino

Baldovino S; Menegatti E; Solfietti L; Naretto C; Bazzan M; Rossi D; Sciascia S; Roccatello D;

The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents. in Oncotarget / Oncotarget. 2017 Jun 20;8(25):41764-41777. doi: 10.18632/oncotarget.16986.

2017
ASL Città di Torino

Menegatti E; Fenoglio R; Solfietti L; Rossi D; Sciascia S; Roccatello D; Baldovino S;

Rate of Adverse Effects of Medium- to High-Dose Glucocorticoid Therapy in Systemic Lupus Erythematosus: A Systematic Review of Randomized Control Trials. in Clinical drug investigation / Clin Drug Investig. 2017 Jun;37(6):519-524. doi: 10.1007/s40261-017-0518-z.

2017
ASL Città di Torino

Cuadrado MJ; Radin M; Roccatello D; Sciascia S; Mompean E;

Antiphospholipid antibodies: crossroads between autoimmunity and infections? in Internal and emergency medicine / Intern Emerg Med. 2017 Jun;12(4):557-558. doi: 10.1007/s11739-017-1664-2. Epub 2017 Apr 12.

2017
ASL Città di Torino

Roccatello D; Sciascia S; Radin M; Bazzan M;

Novel diagnostic and therapeutic frontiers in thrombotic anti-phospholipid syndrome. in Internal and emergency medicine / Intern Emerg Med. 2017 Feb;12(1):1-7. doi: 10.1007/s11739-016-1596-2. Epub 2017 Jan 2.

2017
ASL Città di Torino

Sciascia S; Radin M; Bazzan M; Roccatello D;

Infliximab Biosimilars in the Treatment of Inflammatory Bowel Diseases: A Systematic Review. in BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy / BioDrugs. 2017 Feb;31(1):37-49. doi: 10.1007/s40259-016-0206-1.

2017
ASL Città di Torino

Cuadrado MJ; Roccatello D; Sciascia S; Radin M;

Chronic kidney disease and anticoagulation: from vitamin K antagonists and heparins to direct oral anticoagulant agents. in Internal and emergency medicine / Intern Emerg Med. 2017 Dec;12(8):1101-1108. doi: 10.1007/s11739-017-1753-2. Epub 2017 Sep 19.

2017
ASL Città di Torino

Fenoglio R; Baldovino S; Radin M; Schreiber K; Sciascia S; Roccatello D;

Current insights in obstetric antiphospholipid syndrome. in Current opinion in obstetrics & gynecology / Curr Opin Obstet Gynecol. 2017 Dec;29(6):397-403. doi: 10.1097/GCO.0000000000000406.

2017
ASL Città di Torino

Schreiber K; Radin M; Sciascia S;

The "4 plus 2" rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study. in Oncotarget / Oncotarget. 2017 May 23;8(32):52072-52077. doi: 10.18632/oncotarget.18120. eCollection 2017 Aug 8.

2017
ASL Città di Torino

Menegatti E; Baldovino S; Fenoglio R; Radin M; Naretto C; Alpa M; Sciascia S; Rossi D; Roccatello D;

The adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarction. in International journal of cardiology / Int J Cardiol. 2017 Aug 1;240:72-77. doi: 10.1016/j.ijcard.2017.02.155. Epub 2017 Mar 24.

2017
ASL Città di Torino

Sciascia S; Bazzan M; Cuadrado MJ; Baldovino S; Roccatello D; Radin M; Schreiber K; Costanzo P; Cecchi I;

Expanding the therapeutic options for renal involvement in lupus: eculizumab, available evidence. in Rheumatology international / Rheumatol Int. 2017 Aug;37(8):1249-1255. doi: 10.1007/s00296-017-3686-5. Epub 2017 Mar 3.

2017
ASL Città di Torino

Dall'Era M; Roccatello D; Cecchi I; Tektonidou M; Yazdany J; Sciascia S; Radin M;

Immunological Rare Diseases. in Advances in experimental medicine and biology / Adv Exp Med Biol. 2017;1031:497-509. doi: 10.1007/978-3-319-67144-4_26.

2017
ASL Città di Torino

Baldovino S; Menegatti E; Roccatello D; Sciascia S;

High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study in American Journal of Nephrology

2017
ASL Città di Torino

Roccatello D; Sciascia S; Rossi D; Alpa M; Naretto C; Radin M; Barreca A; Fenoglio R; Baldovino S; Menegatti E;

High doses of rituximab are ineffective in adult patients with focal segmental glomerulosclerosis in Journal of the American Society of Nephrology

2017
ASL Città di Torino

Roccatello D; Sciascia S; Fenoglio R;

Safety profile of outpatient percutaneous native renal biopsy: A large monocentric single operator cohort in Journal of the American Society of Nephrology

2017
ASL Città di Torino

Roccatello D; Sciascia S; Fenoglio R;

Effects of high titers of anti-chimeric antibodies following rituximab in Journal of the American Society of Nephrology

2017
ASL Città di Torino

Roccatello D; Sciascia S; Fenoglio R;

Timing the effect of rituximab on peripheral CD 20+b cells: An in vivo experience in Journal of the American Society of Nephrology

2017
ASL Città di Torino

Roccatello D; Sciascia S; Fenoglio R;

Effects of rituximab in adult patients with minimal change disease in Journal of the American Society of Nephrology

2017
ASL Città di Torino

Roccatello D; Sciascia S; Fenoglio R;

Non-vitamin K antagonist oral anticoagulants and antiphospholipid syndrome. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2016 Oct;55(10):1726-35. doi: 10.1093/rheumatology/kev445. Epub 2016 Feb 3.

2016
ASL Città di Torino

Cuadrado MJ; Roccatello D; Pecoraro C; Cecchi I; Lopez-Pedrera C; Sciascia S;

New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: A prospective study and a review of the literature. in Autoimmunity reviews / Autoimmun Rev. 2016 Jun;15(6):529-38. doi: 10.1016/j.autrev.2016.02.014. Epub 2016 Feb 11.

2016
ASL Città di Torino

Menegatti E; Baldovino S; Fenoglio R; Naretto C; Solfietti L; Di Simone D; Sciascia S; Roccatello D;

Antiphospholipid syndrome. in Best practice & research. Clinical rheumatology / Best Pract Res Clin Rheumatol. 2016 Feb;30(1):133-48. doi: 10.1016/j.berh.2016.04.002. Epub 2016 May

2016
ASL Città di Torino

Khamashta M; Taraborelli M; Sciascia S; Tincani A;

Patients with antiphosholipid syndrome and thrombotic recurrences: A real world observation (the Piedmont cohort study). in Lupus / Lupus. 2016 Apr;25(5):479-85. doi: 10.1177/0961203315617538. Epub 2015 Dec 8.

2016
ASL Città di Torino

Montaruli B; Sciascia S; Stella S; Vaccarino A; Bazzan M; Bertero MT; Carignola R; Roccatello D;

Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assay. in Clinical and molecular allergy : CMA / Clin Mol Allergy. 2016 Jul 15;14:6. doi: 10.1186/s12948-016-0043-2. eCollection 2016.

2016
ASL Città di Torino

Roccatello D; Menegatti E; Erkan D; Cuadrado MJ; Radin M; Schreiber K; Solfietti L; Baldovino S; Sciascia S;

Emerging therapies in systemic lupus erythematous: from clinical trial to the real life. in Expert review of clinical pharmacology / Expert Rev Clin Pharmacol. 2016;9(5):681-94. doi: 10.1586/17512433.2016.1155446. Epub 2016 Mar 10.

2016
ASL Città di Torino

Cuadrado MJ; Chambers W; Sciascia S; Zhang H;

Improved (4 Plus 2) Rituximab Protocol for Severe Cases of Mixed Cryoglobulinemia: A 6-Year Observational Study. in American journal of nephrology / Am J Nephrol. 2016;43(4):251-60. doi: 10.1159/000445841. Epub 2016 Apr 29.

2016
ASL Città di Torino

Alpa M; Naretto C; Di Simone D; Menegatti E; Rossi D; Sciascia S; Baldovino S; Roccatello D;

Risk factors for a thrombotic event in patients with systemic lupus erythematosus and antiphospholipid antibodies: A prospective 10-years followup study in Clinical and Experimental Rheumatology

2016
ASL Città di Torino

Castagno I; Kuzenko A; Sciascia S; Bertero MT;

Thrombin generation assay and autoimmune bullous diseases in Oral Diseases

2016
ASL Città di Torino

Cabras M; Arduino PG; Sciascia S; Radin M; Solfietti L; Di Simone D; Giancaspero K; Menegatti E; Baldovino S;

Antiphospholipid Syndrome and the Kidney. in Seminars in nephrology / Semin Nephrol. 2015 Sep;35(5):478-86. doi: 10.1016/j.semnephrol.2015.08.009.

2015
ASL Città di Torino

Schreiber K; Baldovino S; Sciascia S; Solfietti L; Roccatello D;

A 4-year observation in lupus nephritis patients treated with an intensified B-lymphocyte depletion without immunosuppressive maintenance treatment-Clinical response compared to literature and immunological re-assessment. in Autoimmunity reviews / Autoimmun Rev. 2015 Dec;14(12):1123-30. doi: 10.1016/j.autrev.2015.07.017. Epub 2015 Aug 2.

2015
ASL Città di Torino

Simoncini M; Di Simone D; Naretto C; Alpa M; Rossi D; Baldovino S; Sciascia S; Roccatello D; Menegatti E;

Rheumatoid arthritis: Biological therapy other than anti-TNF. in International immunopharmacology

2015
ASL Città di Torino

Rossi D; Modena V; Sciascia S; Roccatello D;

The role of nail-videocapillaroscopy in early diagnosis of scleroderma. in Autoimmunity reviews

2013
ASL Città di Torino

Rossi D; Russo A; Manna E; Binello G; Baldovino S; Sciascia S; Roccatello D;

C1 esterase inhibitor deficiency and SLE: A case report and review of the literature in Molecular Immunology

2013
ASL Città di Torino

Baldovino S; Naretto C; Mereuta M; Sciascia S; Manna E; Salussolia I; Strani G; Giancaspero K; Menegatti E; Roccatello D;

Association between hereditary angioedema and lupus erythematosus in the mother and the son in Journal of Clinical Immunology

2012
ASL Città di Torino

Roccatello D; Strani G; Salussolia I; Manna E; Sciascia S; Mereuta M; Carla N; Baldovino S; Binello G;

Antiphospholipid syndrome in northwest Italy (APS Piedmont Cohort): Demographic features, risk factors, clinical and laboratory profile in Lupus

2012
ASL Città di Torino
AOU San Luigi di Orbassano

Bertero MT; Bazzan M; Carignola R; Montaruli B; Silvestro E; Sciascia S; Vaccarino A; Baldovino S; Roccatello D;

Oxidative stress and airway inflammation after allergen challenge evaluated by exhaled breath condensate analysis. in Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology / Clin Exp Allergy. 2010 Nov;40(11):1642-7. doi: 10.1111/j.1365-2222.2010.03604.x. Epub 2010 Aug 18.

2010
AO Ordine Mauriziano
ASL Città di Torino

Brussino L; Badiu I; Sciascia S; Bugiani M; Heffler E; Guida G; Malinovschi A; Bucca C; Rolla G;

Antiphospholipid antibodies and systemic lupus erythematosus: Risk scale for the diagnosis of antiphospholipid syndrome in Lupus

2010
ASL Città di Torino
AO Ordine Mauriziano

Sciascia S; Bertero MT; Cosseddu D; Kuzenko A; Rolla G; Roccatello D;

Usefulness of exhaled nitric oxide (FeNO) measured by a portable analyzer to diagnose Cough Variant asthma in a clinical setting of chronic cough in Allergy: European Journal of Allergy and Clinical Immunology

2009
ASL Città di Torino
AO Ordine Mauriziano

Pizzimenti S; Heffler E; Piccioni P; Bugiani M; Migliore E; Guida G; Sciascia S; Carosso A; Rolla G; Asero R; Nebiolo F; Badiu I; Mistrello G; Amato S; Marchese C;